Tech Company Financing Transactions

Congruence Therapeutics Funding Round

Alexandria Venture Investments, Amplitude Ventures and BDC Capital joined a $32 million venture round for Congruence Therapeutics. The financing round was announced on 9/4/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

7171 Rue Frederick-Banting, 117 Montreal
Quebec, H4S 1Z9
CA

Phone

(514) 824-0896

Website

www.congruencetx.com

Email Address

Undisclosed

Overview

Congruence Therapeutics is a drug discovery company that is uniquely harnessing the power of innovative fields such as protein dynamics, biophysics, machine learning and computational chemistry. Our ground-breaking discovery engine, Revenir, sees proteins in ways others have been unable to see - in their full dynamic state.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Clarissa Desjardins

        

Chief Scientific Officer

Sharath Hegde

        

Browse more venture capital transactions:

Prev: 9/3/2025: Xampla venture capital transaction
Next: 9/4/2025: Nanoramic venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary